Christine Lovly Archives
Lovly elected to American Association for Cancer Research board
May. 11, 2023—Christine Lovly, MD, PhD, has been elected to the American Association for Cancer Research board of directors.
Genomic analysis of SCLC tumors reveals subtypes, offers cues toward personalized treatments
May. 11, 2023—The largest genomic analysis ever conducted of small cell lung cancer tumors (SCLC) has identified genetic subtypes and provided insights into the mechanisms of this aggressive and deadly cancer.
Lovly receives Asclepios Award from GO2 for Lung Cancer
Dec. 8, 2022—Vanderbilt's Christine Lovly, MD, PhD, has received the 2022 Asclepios Award, which recognizes lung cancer research pioneers.
Study reveals need for matching targeted therapies with EGFR subtypes
Jul. 28, 2022—A Vanderbilt study suggests that clinicians should take a deeper dive into distinguishing EGFR mutations when prescribing targeted therapies for non-small-cell lung cancers.
Christine Lovly 2021 recipient of the ECOG-ACRIN Young Investigator Award
Jun. 9, 2021—Christine Lovly, MD, PhD, is the recipient of the 2021 ECOG-ACRIN Young Investigator Award, a major recognition of research excellence.
Vanderbilt researchers present new data on clinical trials at ASCO 2021
May. 26, 2021—Vanderbilt-Ingram Cancer Center researchers will present data on clinical trials involving targeted therapies, immunotherapies and drug combination synergies at the 2021 American Society of Clinical Oncology Annual Meeting, June 4-8. The meeting is a virtual event this year.
Personalized Structural Biology aids cancer treatment decisions
Apr. 8, 2021—Cancer specialists at Vanderbilt University Medical Center, in partnership with biochemists and structural biologists across the Vanderbilt University campus, are taking “personalized” cancer therapy to a new level.
EGFR Resisters/LUNGevity fund lung cancer research
Mar. 18, 2021—Christine Lovly, MD, PhD, associate professor of Medicine in the Division of Hematology and Oncology and Ingram Professor of Cancer Research, is one of two inaugural recipients of the EGFR Resisters/LUNGevity Lung Cancer Research Award.
Gift in memory of Phran Galante boosts lung cancer research
Feb. 25, 2021—A gift in memory of music industry executive and community philanthropist Phran Galante will support the work of Christine Lovly, MD, PhD, associate professor of Medicine and Ingram Professor of Cancer Research, to improve targeted therapies for lung cancer.
Lovly to chair foundation’s scientific leadership board
Oct. 29, 2020—Christine Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, has been named incoming chair of GO2 Foundation's Scientific Leadership Board (SLB).
Diversity role model inspires career path
Oct. 1, 2020—Portia Thomas grew up in Doerun, Georgia, a small, rural city named by pioneer hunters as a place with “a perfect doe run,” where the population has hovered around 800 people for the past 30 years. A childhood impression lifted her aspirations beyond her hometown and inspired her to pursue a career as a physician-scientist.
Early-career investigators
Mar. 12, 2020—Henry Henderson, PhD, was one of 16 researchers selected to participate in the American Association for Cancer Research’s Early-Career Investigator Hill Day on Feb. 27 in Washington, D.C. While there, he met with U.S. Sen. Marsha Blackburn and discussed funding for the National Institutes of Health and the National Cancer Institute with a member of the senator’s health policy staff.
